Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool.
about
Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damageAnalysis of Published Criteria for Clinically Inactive Disease in a Large Juvenile Dermatomyositis Cohort Shows That Skin Disease Is UnderestimatedThe juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomesMyositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.Consensus-based recommendations for the management of juvenile dermatomyositis.In juvenile dermatomyositis, heart rate variability is reduced, and associated with both cardiac dysfunction and markers of inflammation: a cross-sectional study median 13.5 years after symptom onset.Serological subsets of juvenile idiopathic inflammatory myopathies--an update.Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis.213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015Predictors of changes in disease activity among children with juvenile dermatomyositis enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry.
P2860
Q35125063-49D776EA-5BD4-45CE-A506-8FE42E5164F9Q36532789-F91DB4D1-2B41-420D-A2D4-C4A133C8C4A0Q37022721-70E53C00-1FE7-4781-B8C9-AEB249E41BDBQ37368405-785A7078-534B-402B-A9C4-76AF401690EBQ37388175-30A912D1-A40C-4C97-8D37-88C3F86E3B08Q37617000-933F8785-8D99-4122-90F8-0B940F03320DQ38616245-043BFB9E-6E7A-411F-9D15-A5FD49AD1523Q38664251-64260BBD-3F17-4C80-AD80-94F2D131E626Q40479791-E6BBE0A5-E130-4929-AA43-6DB03F319318Q42365042-A379ACC6-1737-4373-8C0D-E67D5221797BQ47820489-83B1CAB6-5B7E-459B-88AC-A8BCFC46F820
P2860
Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Disease activity and prognosti ...... ease activity assessment tool.
@en
Disease activity and prognosti ...... ease activity assessment tool.
@nl
type
label
Disease activity and prognosti ...... ease activity assessment tool.
@en
Disease activity and prognosti ...... ease activity assessment tool.
@nl
prefLabel
Disease activity and prognosti ...... ease activity assessment tool.
@en
Disease activity and prognosti ...... ease activity assessment tool.
@nl
P2860
P356
P1433
P1476
Disease activity and prognosti ...... ease activity assessment tool.
@en
P2093
Berit Flatø
Helga Sanner
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEU146
P577
2014-03-31T00:00:00Z